Scientists developed a new antibiotic (Na+-NQR inhibitor, PEG-2S) to inhibit a nontraditional bacterial target. Results show, for the first time, that Na+-NQR is critical for the bacterial infectious process. Many different diseases caused by pathogenic bacteria rely on Na+-NQR activity for growth.

See the source article by following the link below:
Scientists developed a new antibiotic (Na+-NQR inhibitor, PEG-2S) to inhibit a nontraditional bacterial target. Results show, for the first time, that Na+-NQR is critical for the bacterial infectious process. Many different diseases caused by pathogenic bacteria rely on Na+-NQR activity for growth.